Similar articles

• [Chemotherapy of schistosomiasis in man (a review of the literature)].

  Iarotskiĭ LS. Iarotskiĭ LS. Med Parazitol (Mosk). 1975 May-Jun;44(3):351-9. Med Parazitol (Mosk). 1975. PMID: 1101015 Review. Russian. No abstract available.
• Current results in the clinical therapy of schistosomiasis mansoni.

  Katz N. Katz N. Rev Inst Med Trop Sao Paulo. 1980 Jan-Feb;22(1 Suppl 4):8-17, 123-33. Rev Inst Med Trop Sao Paulo. 1980. PMID: 7006041 Review. English, Portuguese. No abstract available.
• Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. V. Reduction in the degree of resistance to reinfection after chemotherapeutic elimination of recently patent primary infections.

  Doenhoff M, Bickle Q, Bain J, Webbe G, Nelson G. Doenhoff M, et al. J Helminthol. 1980 Mar;54(1):7-16. doi: 10.1017/s0022149x0000626x. J Helminthol. 1980. PMID: 7373025
• Chemotherapy of Schistosomiasis mansoni.

  Katz N. Katz N. Adv Pharmacol Chemother. 1977;14:1-70. doi: 10.1016/s1054-3589(08)60184-2. Adv Pharmacol Chemother. 1977. PMID: 18911 Review. No abstract available.
• Schistosoma mansoni: chemotherapy of infections of different ages.

  Sabah AA, Fletcher C, Webbe G, Doenhoff MJ. Sabah AA, et al. Exp Parasitol. 1986 Jun;61(3):294-303. doi: 10.1016/0014-4894(86)90184-0. Exp Parasitol. 1986. PMID: 3086114